Studies revealed that FATP1 played an irreplaceable role in the fat metabolism and even regarded FATP1 as an important target for the treatment of metabolic diseases such as obesity and Type-II diabetes (17–19). This evidence concerns the gene SLC27A1 and obesity due to melanocortin 4 receptor deficiency.